Atara Biotherapeutics, Inc. (ATRA)

Atara Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	25.99	93.09	106.28	200.6	74.51
Short-Term Investments	25.88	149.88	264.98	300.26	184.79
Cash & Cash Equivalents	51.87	242.97	371.26	500.85	259.3
Cash Growth	-78.65%	-34.56%	-25.87%	93.15%	-16.31%
Receivables	34.11	40.22	0.99	1.25	0
Inventory	9.71	1.59	0	0	0
Other Current Assets	6.18	10.31	12.37	21.17	13.69
Total Current Assets	101.87	295.08	384.62	523.27	272.99
Property, Plant & Equipment	58.79	74.32	79.94	62.82	68.18
Long-Term Investments	0	0	1.2	1.2	1.2
Other Long-Term Assets	4.84	7.02	2.37	0.83	0.57
Total Long-Term Assets	63.64	81.34	83.51	64.85	69.95
Total Assets	165.5	376.42	468.13	588.12	342.94
Accounts Payable	3.68	6.87	17.37	7.12	7.96
Deferred Revenue	115.4	85	96.47	61.25	0
Other Current Liabilities	23.15	-12.96	-8.05	14.53	28.78
Total Current Liabilities	142.23	78.92	105.79	82.9	36.74
Long-Term Debt	80.32	88.3	25.52	13.04	14.14
Other Long-Term Liabilities	42.19	82.56	57.21	29.84	1.28
Total Long-Term Liabilities	122.51	170.86	82.73	42.88	15.42
Total Liabilities	264.74	249.78	188.51	125.78	52.16
Total Debt	80.32	88.3	25.52	13.04	14.14
Debt Growth	-9.04%	246.03%	95.68%	-7.75%	-
Retained Earnings	-1,969.15	-1,693.02	-1,464.72	-1,124.58	-817.96
Comprehensive Income	-0.2	-2.07	-0.37	0.3	0.22
Shareholders' Equity	-99.23	126.64	279.61	462.34	290.78
Net Cash / Debt	-28.45	154.67	345.74	487.81	245.17
Net Cash / Debt Growth	-	-55.27%	-29.12%	98.97%	-20.87%
Net Cash Per Share	-6.71	37.91	92.28	164.86	119.46
Working Capital	-40.36	216.16	278.84	440.37	236.25
Book Value Per Share	-23.42	31.04	74.63	156.25	141.68

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).